Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. AZN
4. SPY
5. ROIV
6. ORCL
7. AAPL
8. HOOD
9. NVDA
10. USO

Go back to Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026
(NASDAQ: OCUL) Delayed: 10.86 +0.22 (2.07%)
Previous Close $10.64    52 Week High $14.50 
Open $10.56    52 Week Low $4.04 
Day High $10.88    P/E N/A 
Day Low $10.40    EPS $0.00 
Volume 230,811